Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
- 1 May 2003
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 97 (3) , 350-354
- https://doi.org/10.1016/s0035-9203(03)90167-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A systematic review of current knowledge of HIV epidemiology and of sexual behaviour in NepalTropical Medicine & International Health, 2002
- Monitoring drug resistance in leishmaniasisTropical Medicine & International Health, 2001
- A policy for leishmaniasis with respect to the prevention and control of drug resistanceTropical Medicine & International Health, 2001
- The increase in risk factors for leishmaniasis worldwidePublished by Oxford University Press (OUP) ,2001
- Visceral leishmaniasis control: a public health perspectiveTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective.The American Journal of Tropical Medicine and Hygiene, 2000
- Miltefosine, an Oral Agent, for the Treatment of Indian Visceral LeishmaniasisNew England Journal of Medicine, 1999
- Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovaniThe Journal of Infectious Diseases, 1999
- LeishmaniasisClinics in Dermatology, 1996
- Visceral leishmaniasis unresponsive to antimonial drugs I. Clinical and immunological studiesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1985